TROG Cancer Research
Members Login   CQMS Login

TROG 11.03 (P_LUNG GP)

Primary sponsor: Trans Tasman Radiation Oncology Group (TROG)


A Randomised Phase III Trial of High Dose Palliative Radiotherapy (HDPRT) Vs Concurrent Chemotherapy + HDPRT in Patients with Locally Advanced/Small Volume Metastatic Non Small Cell Lung Cancer Not Suitable for Radical Chemo-Radiotherapy


The purpose of this study is to investigate whether adding chemotherapy to a short (less than six weeks) course of radiotherapy results in a greater improvement in symptoms and overall wellbeing (quality of life) compared with using a short course of radiotherapy alone in patients with Non-Small Cell Lung Cancer (NSCLC) who cannot be treated with surgery or a long (six weeks or longer) course of radiotherapy and chemotherapy.

Final Accrual


Trial Status

Closed to follow-up, 31 July 2018

Trial chairperson

Associate Professor Margot Lehman, Princess Alexandra Hospital, QLD

Trial contact

Adrienne See
Princess Alexandra Hospital
Phone: +61 7 3176 9116

Further information

TROG trial 11.03 on Australian Cancer Trials website

Trial resources for TROG members

TROG 11.03 member page

We are thankful to our 14,500 patients who have participated in our research. Please continue the generous support.